| NCT ID | NCT03781492 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Silesian Centre for Heart Diseases |
| Condition | Stable Angina |
| Study Type | OBSERVATIONAL |
| Enrollment | 25,000 participants |
| Start Date | 2006-01-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 25,000 participants in total. It began in 2006-01-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Prospective REgistry of Stable Angina manaGEment and Treatment (PRESAGE) is an observational study on an all-comer stable angina population hospitalised in a highly specialized cardiovascular centre with cardiac surgery facilities. The aim of the study is to assess the clinical characteristics, treatment modalities, early and long-term outcomes in this population.
Eligibility Criteria
Inclusion Criteria: * symptom based diagnosis of stable angina Exclusion Criteria: * acute coronary syndrome on admission * ≤ 18 years old
Contact & Investigator
Frequently Asked Questions
Who can join the NCT03781492 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stable Angina. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03781492 currently recruiting?
Yes, NCT03781492 is actively recruiting participants. Contact the research team at desperak.piotr@gmail.com for enrollment information.
Where is the NCT03781492 trial being conducted?
This trial is being conducted at Zabrze, Poland.
Who is sponsoring the NCT03781492 clinical trial?
NCT03781492 is sponsored by Silesian Centre for Heart Diseases. The trial plans to enroll 25,000 participants.